arrows arrow-right arrow-left menu search rss youtube linkedin twitter facebook instagram arrow-play linkedIn

Battelle to Continue Support of CDC Vaccine Research

Posted on Oct 16, 2019

COLUMBUS, Ohio (Oct. 16, 2019)—It’s flu season, and Battelle has won a two-year contract to continue supporting the Centers for Disease Control and Prevention’s (CDC) research on vaccines for influenza strains. The contract, known as Innovation and Expansion of Influenza Candidate Vaccine Virus Development, will help CDC add to its vaccine seed stockpile for any novel flu virus that has potential to become widespread. The goal is to produce candidate vaccine viruses that meet the rigorous quality requirements for use by vaccine manufacturers to produce influenza vaccines. 

The CDC has its own laboratory producing candidate vaccine viruses (CVVs) but also relies on industry contractors such as Battelle to help with its critical role in the development process of influenza CVVs. Timeliness also is part of the equation: Battelle’s help with near-term improvements to CVVs is vital for pandemic preparedness, continuity and response as well as developing seasonal influenza vaccines to protect the public.

Battelle is entering its 20th year of providing continuous on-site support for the CDC. Adding to its advanced biosafety capabilities, biocontainment labs and decontamination expertise, Battelle has created its own dedicated lab to conduct flu vaccine preparedness work. Battelle researchers predict which vaccine strains might be needed and use reverse genetics to create strains in the laboratory that elicit the necessary antibody response to facilitate rapid mass production of flu vaccines.

“This is important work and reinforces that Battelle is dedicated to the health of our society and to our relationship with the CDC,” said Sanjeeth Pai, vice president and general manager of Battelle’s health research and technology business. 

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit

Media Contacts

For more information contact Katy Delaney at (614) 424-7208 or or T.R. Massey at (614) 424-5544 or

Media Contacts

Katy Delaney
Director, Media Relations
Office: 1.614.424.7208

T.R. Massey

Senior Media Specialist
Office: 1.614.424.5544